Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3
Publication
, Journal Article
Luo, X
Published in: TRANSPLANTATION
2021
Duke Scholars
Published In
TRANSPLANTATION
EISSN
1534-6080
ISSN
0041-1337
Publication Date
2021
Volume
105
Issue
7
Start / End Page
1392 / 1392
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Luo, X. (2021). Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3. TRANSPLANTATION, 105(7), 1392–1392.
Luo, Xunrong. “Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3.” TRANSPLANTATION 105, no. 7 (2021): 1392–1392.
Luo X. Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3. TRANSPLANTATION. 2021;105(7):1392–1392.
Luo, Xunrong. “Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3.” TRANSPLANTATION, vol. 105, no. 7, 2021, pp. 1392–1392.
Luo X. Pazopanib Ameliorates Acute Lung Injuries via Inhibition of MAP3K2 and MAP3K3. TRANSPLANTATION. 2021;105(7):1392–1392.
Published In
TRANSPLANTATION
EISSN
1534-6080
ISSN
0041-1337
Publication Date
2021
Volume
105
Issue
7
Start / End Page
1392 / 1392
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences